CR8862A - DERIVATIVES OF POLISACARIDS AND THEIR USES IN THE INDUCTION OF AN IMMUNE RESPONSE - Google Patents

DERIVATIVES OF POLISACARIDS AND THEIR USES IN THE INDUCTION OF AN IMMUNE RESPONSE

Info

Publication number
CR8862A
CR8862A CR8862A CR8862A CR8862A CR 8862 A CR8862 A CR 8862A CR 8862 A CR8862 A CR 8862A CR 8862 A CR8862 A CR 8862A CR 8862 A CR8862 A CR 8862A
Authority
CR
Costa Rica
Prior art keywords
acetylated
derivatives
derivative
polisacarids
induction
Prior art date
Application number
CR8862A
Other languages
Spanish (es)
Inventor
R Moe Gregory
M Granoff Dan
Original Assignee
Childrens Hosp & Res Ct Oak
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Hosp & Res Ct Oak filed Critical Childrens Hosp & Res Ct Oak
Publication of CR8862A publication Critical patent/CR8862A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185—Escherichia
    • C12R2001/19—Escherichia coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/36—Neisseria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente invencion en general proporciona composiciones que presentan un derivado de polisacarido, y metodos para su preparacion y uso para la prevencion o tratamiento de enfermedades causadas por bacterias Neisseria meningitidis, particularmente cepas (NmB) del grupo B, y por E.coIi Kl. La invencion proporciona un derivado PS des-N-acetilado en el cual uno o mas residuos de PS han sido modificados por la de-N-acetilacion. La invencion tambien incluye derivadas en los cuales uno o mas de los grupos N-acetilo de PS que contienen los PS de-N-acetilados se reemplazan con otros grupos N-acilo, usualmente un grupo acilo menor con 2 o 3 atomos de carbono. Ademas la invencion incluye los derivados de PS des-Nacetilados que contienen hidrocarburos de cadena larga asi como conjugados en los cuales el derivado de PS des-N-acetilados se liga a un portador, por ejemplo una proteina portadora.The present invention generally provides compositions presenting a polysaccharide derivative, and methods for its preparation and use for the prevention or treatment of diseases caused by Neisseria meningitidis bacteria, particularly strains (NmB) of group B, and by E.coIi Kl. The invention provides a de-N-acetylated PS derivative in which one or more PS residues have been modified by de-N-acetylation. The invention also includes derivatives in which one or more of the N-acetyl groups of PS containing de-N-acetylated PSs are replaced with other N-acyl groups, usually a smaller acyl group with 2 or 3 carbon atoms. In addition, the invention includes de-Nacetylated PS derivatives containing long chain hydrocarbons as well as conjugates in which the de-N-acetylated PS derivative is linked to a carrier, for example a carrier protein.

CR8862A 2004-06-23 2007-01-18 DERIVATIVES OF POLISACARIDS AND THEIR USES IN THE INDUCTION OF AN IMMUNE RESPONSE CR8862A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58267204P 2004-06-23 2004-06-23

Publications (1)

Publication Number Publication Date
CR8862A true CR8862A (en) 2007-07-24

Family

ID=35782376

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8862A CR8862A (en) 2004-06-23 2007-01-18 DERIVATIVES OF POLISACARIDS AND THEIR USES IN THE INDUCTION OF AN IMMUNE RESPONSE

Country Status (14)

Country Link
US (2) US7595307B2 (en)
EP (1) EP1784428A2 (en)
JP (1) JP2008509886A (en)
KR (1) KR20070060069A (en)
AU (1) AU2005258301A1 (en)
BR (1) BRPI0512413A (en)
CA (1) CA2568982A1 (en)
CR (1) CR8862A (en)
EC (1) ECSP077129A (en)
IL (1) IL179642A0 (en)
MX (1) MXPA06015107A (en)
NO (1) NO20070434L (en)
RU (1) RU2404995C2 (en)
WO (1) WO2006002402A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8148335B2 (en) 2004-06-23 2012-04-03 Children's Hospital & Research Center Oakland De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
BRPI0512413A (en) 2004-06-23 2008-03-04 Childrens Hosp & Res Ct Oak polysaccharide derivatives and uses in inducing an immune response
CA2620416A1 (en) * 2005-08-24 2007-03-01 Novartis Vaccines And Diagnostics S.R.L. Zwitterionization of capsular saccharides
WO2007075921A2 (en) * 2005-12-23 2007-07-05 Children's Hospital & Research Center At Oakland De-n-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
CA2692069C (en) * 2007-06-20 2016-10-18 Baxter Healthcare S.A. Modified polysaccharides for conjugate vaccines
WO2009006620A1 (en) 2007-07-03 2009-01-08 Children's Hospital & Research Center At Oakland Oligosialic acid derivatives, methods of manufacture, and immunological uses
AU2008272854B2 (en) * 2007-07-03 2014-03-13 Children's Hospital & Research Center At Oakland Inhibitors of polysialic acid de-N-acetylase and methods for using the same
WO2009006613A1 (en) 2007-07-03 2009-01-08 Children's Hospital & Research Center At Oakland Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting
US20130116423A1 (en) 2010-04-23 2013-05-09 A. Stewart Campbell Synthetic Oligosaccharides for Staphylococcus Vaccine
US8716469B2 (en) 2010-04-27 2014-05-06 Ancora Pharmaceuticals, Inc. Synthetic oligosaccharides for Moraxella vaccine
WO2011149778A1 (en) 2010-05-26 2011-12-01 Ancora Pharmaceuticals Inc. Synthetic oligosaccharides for neisseria meningitis vaccine
CN109182423B (en) * 2018-09-26 2020-07-07 武汉中科光谷绿色生物技术有限公司 Method for promoting fermentation of escherichia coli to produce polysialic acid
CN112795583A (en) * 2020-11-16 2021-05-14 上海大学 Preparation method of recombinant sialic acid exonuclease, expression gene, recombinant expression vector and construction method
CN114507262B (en) * 2022-03-01 2023-12-19 德元堂(上海)健康科技发展有限公司 Hydrolysis process of polysialic acid
CN114539333B (en) * 2022-03-01 2023-12-22 德元堂(上海)健康科技发展有限公司 Cyclic production process of sialic acid

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314999A (en) * 1978-07-31 1982-02-09 Proter S.P.A. N-Acyl derivatives of glucosamine having antitumor chemotherapeutic acitivity
US4216208A (en) * 1978-07-31 1980-08-05 Proter S.P.A. N-Acyl derivatives of glucosamines having antitumor chemotherapeutic activity
US4727136A (en) 1985-10-01 1988-02-23 Canadian Patents And Development Ltd. Modified meningococcal group B polysaccharide for conjugate vaccine
US4722136A (en) * 1985-10-28 1988-02-02 Leviton Manufacturing Company, Inc. Snap-in convenience electrical connector system and method of assembly
JPS6344590A (en) * 1986-08-12 1988-02-25 Mect Corp Production of sialic acid derivative
HU9201966D0 (en) 1989-12-14 1992-10-28 Ca Nat Research Council An improved vaccine of meningococcus-polysaccharide conjunction
US5846951A (en) * 1991-06-06 1998-12-08 The School Of Pharmacy, University Of London Pharmaceutical compositions
GB9116896D0 (en) * 1991-08-06 1991-09-18 Erba Carlo Spa 3-deoxymannosamine derivatives and process for their preparation
US5811102A (en) * 1995-06-07 1998-09-22 National Research Council Of Canada Modified meningococcal polysaccharide conjugate vaccines
JPH101397A (en) * 1996-06-14 1998-01-06 Mitsubishi Gas Chem Co Inc Garnet crystal for substrate of magneto-optical element and method for producing the same
JP4150082B2 (en) * 1996-08-27 2008-09-17 カイロン コーポレイション Monoclonal antibodies defining unique meningococcal B epitopes and their use in the preparation of vaccine compositions
ES2166097T5 (en) * 1996-08-27 2007-03-16 Novartis Vaccines And Diagnostics, Inc. NEISSERIA GLICOCONJUGADOS OF SEROGROUP B MENINGITIDIS AND PROCEDURES FOR USE.
ATE421527T1 (en) 1997-08-27 2009-02-15 Novartis Vaccines & Diagnostic MOLECULAR MIMETICS OF MENINGOCOCCUS B EPITOPES
WO2000007602A1 (en) * 1998-08-06 2000-02-17 The Johns Hopkins University School Of Medicine Compounds for altering cell surface sialic acids and methods of use therefor
CA2279134A1 (en) * 1999-07-29 2001-01-29 Tianmin Liu Novel strategy for carbohydrate-based therapeutic vaccines
AU2001278323A1 (en) * 2000-07-28 2002-02-13 National Research Council Of Canada Modified sialic acid vaccines
BRPI0512413A (en) 2004-06-23 2008-03-04 Childrens Hosp & Res Ct Oak polysaccharide derivatives and uses in inducing an immune response

Also Published As

Publication number Publication date
MXPA06015107A (en) 2007-03-26
WO2006002402A3 (en) 2006-05-04
NO20070434L (en) 2007-03-20
US20100068728A1 (en) 2010-03-18
RU2404995C2 (en) 2010-11-27
BRPI0512413A (en) 2008-03-04
WO2006002402A2 (en) 2006-01-05
RU2007102255A (en) 2008-07-27
US7595307B2 (en) 2009-09-29
CA2568982A1 (en) 2006-01-05
IL179642A0 (en) 2007-05-15
JP2008509886A (en) 2008-04-03
KR20070060069A (en) 2007-06-12
AU2005258301A1 (en) 2006-01-05
US20070010482A1 (en) 2007-01-11
EP1784428A2 (en) 2007-05-16
ECSP077129A (en) 2007-02-28

Similar Documents

Publication Publication Date Title
CR8862A (en) DERIVATIVES OF POLISACARIDS AND THEIR USES IN THE INDUCTION OF AN IMMUNE RESPONSE
BRPI0607374A2 (en) gna1870-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis
PA8790201A1 (en) CYTOTOXIC AGENTS UNDERSTANDING NEW TOMAIMYCIN DERIVATIVES AND THERAPEUTIC USE
CR20110206A (en) METHOD OF USE OF A SEPA DE BACILLUS SUBTILIS TO IMPROVE ANIMAL HEALTH
BRPI0612670B8 (en) immunogenic composition, vaccine comprising and vaccine kit for concomitant or sequential administration
DK1648505T3 (en) Low toxicity quil A fraction and its use
PE20080748A1 (en) VACCINE BASED ON THE NEISSERIA STRAINS
BRPI0519242A2 (en) use 1-aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional instability and pseudobulbar paralysis
BRPI0515316A (en) imidazoquinoline compounds
BR112012004696B8 (en) TLR activity modulator compound, its use, pharmaceutical composition, drug, kit and combination
CO2023016246A2 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and their uses
CL2004001550A1 (en) FORMULA FOR INFANTS OR FOR NEXT STAGE OF THE GROWTH, THAT INCLUDES PROTEINS, LIPIDS, CARBOHYDRATES AND A PROBIOTICO, WHERE THE LIPID SOURCE INCLUDES AT LEAST ONE LC-PUFA, AND ITS USES.
EA200601761A1 (en) COMPOSITIONS AS ADJUVANTS FOR STRENGTHENING IMMUNE RESPONSES TO VACCINES AND METHODS OF THEIR USE
CR10149A (en) CYTOTOXIC AGENTS UNDERSTANDING NEW TOMAIMYCIN DERIVATIVES AND THERAPEUTIC USE
EA201101164A1 (en) IMMUNOGENIC COMPOSITION
BR112013006396A2 (en) immunogenic compositions
BRPI0413241A (en) monatin table sweetener compositions and methods of making the same
BR112015004515A2 (en) immunogenic composition
CL2009000757A1 (en) Compounds derived from 6,8,2'-tris- (isobut-2-en-1-yl) -diosmethine; procedures for its preparation; pharmaceutical composition comprising them; and its use in the treatment of chronic venous diseases, post-thrombotic syndrome, vascular complications linked to diabetes, among others.
EA200870421A1 (en) ARTEMIZININ DERIVATIVE DIMERAS, THEIR RECEIVING AND THEIR APPLICATION IN THERAPY
BR112015032200A2 (en) antibody-drug conjugate with improved stability, method of preparation, pharmaceutical composition and use thereof
MX2010009147A (en) Pyrrolidinyl derivatives and uses thereof.
BRPI0810130A8 (en) BEVERAGE COMPOSITION, PROCESS FOR PRODUCING A BEVERAGE COMPOSITION, AND, USE OF A BEVERAGE COMPOSITION
ES2570990T3 (en) Fermented food containing bifidobacterium bacteria and method to produce it
CO2021014748A2 (en) Anti-bcma antibody conjugate, compositions comprising it, and methods of making and using the same

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)